ConductScience.org, home

Trial · NCT03229057

Results by group24

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With Metabolic Syndrome After 6 Months of Treatment Metformin or OCP+Metformin for 6 Months.OCP + Placebo17Participants
Number of Participants With Metabolic Syndrome After 6 Months of Treatment Metformin or OCP+Metformin for 6 Months.Metformin + Placebo17Participants
Number of Participants With Metabolic Syndrome After 6 Months of Treatment Metformin or OCP+Metformin for 6 Months.OCP + Metformin18Participants
Changes in Serum Apoliprotein B From Baseline to 6 MonthsOCP + Placebo.03Inter-Quartile Range -0.02 to 0.06g/L
Changes in Serum Apoliprotein B From Baseline to 6 MonthsMetformin + Placebo0.003Inter-Quartile Range -0.03 to 0.04g/L
Changes in Serum Apoliprotein B From Baseline to 6 MonthsOCP + Metformin0.05Inter-Quartile Range 0.01 to 0.09g/L
Changes in Total Body Fat Distribution in the 3 Arms From Baseline to 6 MonthsOCP + Placebo-0.83Inter-Quartile Range -1.65 to -0.01kg
Changes in Total Body Fat Distribution in the 3 Arms From Baseline to 6 MonthsMetformin + Placebo-0.48Inter-Quartile Range -1.24 to 0.28kg
Changes in Total Body Fat Distribution in the 3 Arms From Baseline to 6 MonthsOCP + Metformin0.06Inter-Quartile Range -0.70 to 0.82kg
Changes in Total Triglyceride-Rich Lipoprotein (TRLP) From Baseline to 6 MonthsOCP + Placebo-2.26Inter-Quartile Range -0.02 to 0.06mol/L
Changes in Total Triglyceride-Rich Lipoprotein (TRLP) From Baseline to 6 MonthsMetformin + Placebo6.33Inter-Quartile Range -5.35 to 18.02mol/L
Changes in Total Triglyceride-Rich Lipoprotein (TRLP) From Baseline to 6 MonthsOCP + Metformin10.24Inter-Quartile Range -1.70 to 22.18mol/L
Changes in Serum Marker of Inflammation: Free Fatty Acids.OCP + Placebo0.04Inter-Quartile Range -0.02 to 0.10mEq/L
Changes in Serum Marker of Inflammation: Free Fatty Acids.Metformin + Placebo-0.03Inter-Quartile Range -0.09 to 0.03mEq/L
Changes in Serum Marker of Inflammation: Free Fatty Acids.OCP + Metformin0.09Inter-Quartile Range 0.03 to 0.15mEq/L
Changes in Quality of Life Parameters for Body Hair in All 3 Arms as Assessed by PCOSQ From Baseline to 6 MonthsOCP + Placebo0.74Inter-Quartile Range 0.46 to 1.02score on a scale
Changes in Quality of Life Parameters for Body Hair in All 3 Arms as Assessed by PCOSQ From Baseline to 6 MonthsMetformin + Placebo0.26Inter-Quartile Range -0.01 to 0.53score on a scale
Changes in Quality of Life Parameters for Body Hair in All 3 Arms as Assessed by PCOSQ From Baseline to 6 MonthsOCP + Metformin0.62Inter-Quartile Range 0.35 to 0.90score on a scale
Changes in Visceral Body Fat Distribution in the 3 ArmsOCP + Placebo-167Inter-Quartile Range -264 to -71g
Changes in Visceral Body Fat Distribution in the 3 ArmsMetformin + Placebo-86Inter-Quartile Range -176 to 4g

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03229057/results